Dexamethasone
DEXTENZA, Dexamethasone, Dexycu, Hemady, MAXIDEX, OZURDEX, TaperDex 12-day, TaperDex 6-day
Corticosteroid
NADAC/unit
$0.0298
Active Shortage
Tier 1: 250.5%
PA Req: 1.5%
20 Manufacturers
70 ANDAs
Dexamethasone reduces inflammation and suppresses immune responses, used across many conditions.
vs. brand DEXTENZA: Generic saves up to 100% per unit
Active Shortages
2019-02-08 Product will be made available as it is released., Hikma Pharmaceuticals USA, Inc.
2019-02-08 Product temporarily on backorder. Additional lots will be available in the April 2026 timefrime, Hikma Pharmaceuticals USA, Inc.
2019-02-08 Check wholesalers for inventory, Fresenius Kabi USA, LLC
2019-02-08 Shortage reported, Mylan Institutional, a Viatris Company
2019-02-08 Expected recovery: TBD, Fresenius Kabi USA, LLC
Market Intelligence
2024-06-26 Class II Recall: Eugia US LLC
Generic Manufacturers
ABBVIE INCALVOGEN INCAMNEAL EU LTDAPOTEX INCBAUSCH AND LOMB PHARMACEUTICALS INCBIONPHARMA INCCHARTWELL MOLECULAR HOLDINGS LLCCOREPHARMA LLCDEXCEL PHARMA TECHNOLOGIES LTDEUGIA PHARMA SPECIALITIES LTDEYEPOINT PHARMACEUTICALS INCFRESENIUS KABI USA LLCGLAND PHARMA LTDHARROW EYE LLCHIKMA PHARMACEUTICALS USA INCKANCHAN HEALTHCARE INCMICRO LABS LTDMYLAN LABORATORIES LTDNOVITIUM PHARMA LLCOCULAR THERAPEUTIX INCPHARMOBEDIENT CONSULTING LLCPRASCO LLC DBA PRASCO LABORATORIESRISING PHARMA HOLDINGS INCSOMERSET THERAPEUTICS LLCZYDUS LIFESCIENCES LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.